Evolution of an influenza pandemic in 13 countries from 5 continents monitored by protein microarray from neonatal screening bloodspots

Journal of Clinical Virology

Volumn 61, Issue 1, 2014, Pages 74-80

  De Bruin, E ^a   Loeber, J G ^a   Meijer, A ^a   Castillo, G Martinez ^b   Cepeda, M L Granados ^c   Torres Sepúlveda, M Rosario ^d   Borrajo, G J C ^e   Caggana, M ^f   Giguere, Y ^g   Meyer, M ^h   Fukushi, M ⁱ   Devi, A R Rama ^j   Khneisser, I ^k   Vilarinho, L ^l   von Dobeln U ^m   Torresani, T ⁿ   Mackenzie, J ^o   Zutt, I ^a   Schipper, M ^a   Elvers, L H ^a   Koopmans, M P G ^a,p   more..

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b HOSPITAL ESPAÑOL DE MÉXICO   (Mexico)

^c Instituto Naciional de Perinatologia   (Mexico)

^d Medicina UANL   (Mexico)

^e Fundacion Bioquimica Argentina   (Argentina)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^g LAVAL UNIVERSITY   (Canada)

^h NORTH WEST UNIVERSITY   (South Africa)

ⁱ Sapporo City Institute of Public Health   (Japan)

^j Rainbow Children's Hospital   (India)

^k SAINT JOSEPH UNIVERSITY   (Lebanon)

^l NATIONAL INSTITUTE OF HEALTH   (Portugal)

^m KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁿ Universitats Kinderklinik   (Switzerland)

^o ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^p ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Dried bloodspots; Influenza virus; Neonatal screening; Pandemic; Protein microarray

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ARTICLE; DRIED BLOOD SPOT TESTING; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA VIRUS; MOLECULAR EVOLUTION; NEWBORN; NEWBORN SCREENING; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROTEIN MICROARRAY; SEASONAL INFLUENZA; SEROPREVALENCE; VIRUS DETECTION; VIRUS GENOME; VIRUS STRAIN; VIRUS TRANSMISSION; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; DIAGNOSTIC USE; FEMALE; HEALTH; IMMUNOLOGY; INFANT; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PANDEMIC; PREGNANCY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; GLOBAL HEALTH; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEONATAL SCREENING; PANDEMICS; PREGNANCY; PROTEIN ARRAY ANALYSIS; YOUNG ADULT;

EID: 84905090850     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.06.020     Document Type: Article

References (28)

1. Girard M.P., Tam J.S., Assossou O.M., Kieny M.P. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010, 28(31):4895-4902.
2. Briand S., Mounts A., Chamberland M. Challenges of global surveillance during an influenza pandemic. Public Health 2011, 125(5):247-256.
3. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(20):1945-1952.
4. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375(9720):1100-1108.
5. Wood J.M., Major D., Heath A., Newman R.W., Hoschler K., Stephenson I., et al. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO international standard. Vaccine 2012, 30(2):210-217.
6. Laurie K.L., Huston P., Riley S., Katz J.M., Willison D.J., Tam J.S., et al. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting. Influenza Other Respir Viruses 2013, 7(2):211-224.
7. Broberg E., Nicoll A., Amato-Gauci A. Seroprevalence to influenza A(H1N1) 2009 virus?-where are we?. Clin Vaccine Immunol 2011, 18(8):1205-1212.
8. Stephenson I., Heath A., Major D., Newman R.W., Hoschler K., Junzi W., et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009, 15(8):1252-1259.
9. Sahai I., Marsden D. Newborn screening. Crit Rev Clin Lab Sci 2009, 46(2):55-82.
10. Mei J.V., Zobel S.D., Hall E.M., De Jesus V.R., Adam B.W., Hannon W.H. Performance properties of filter paper devices for whole blood collection. Bioanalysis 2010, 2(8):1397-1403.
11. Snijdewind I.J., van Kampen J.J., Fraaij P.L., van der Ende M.E., Osterhaus A.D., Gruters R.A. Current and future applications of dried blood spots in viral disease management. Antivir Res 2012, 93(3):309-321.
12. Bertagnolio S., Parkin N.T., Jordan M., Brooks J., Garcia-Lerma J.G. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev 2010, 12(4):195-208.
13. Koopmans M., de Bruin E., Godeke G.J., Friesema I., van Gageldonk R., Schipper M., et al. Profiling of humoral immune responses to influenza viruses by using protein microarray. Clin Microbiol Infect 2012, 18(8):797-807.
14. Anonymous. Newborn Screening Quality Assurance Program: Centers for Disease Control and Prevention; February 2010: 2010.
15. Control NIBSC Influenza Reagent Candidate International Standard for Antibody to Influenza H1N1pdm Virus. NIBSC code 09/194 Version 20 2010, Health Protection Agency, Ridge, United Kingdom.
16. Wood S.N. Generalized additive models: an introduction with R 2006, Chapman and Hall/CRC.
17. Wood S.N. Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models. J R Stat Soc: Series B (Statistical Methodology) 2011, 73(1):3-36.
18. Wood S.N. Thin plate regression splines. J R Stat Soc: Series B (Statistical Methodology) 2003, 65(1):95-114.
19. Wood S.N. Stable and efficient multiple smoothing parameter estimation for generalized additive models. J Am Stat Assoc 2004, 99:673-686.
20. R Development Core Team R: A language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
21. Broor S., Krishnan A., Roy D.S., Dhakad S., Kaushik S., Mir M.A., et al. Dynamic patterns of circulating seasonal and pandemic A(H1N1)pdm09 influenza viruses from 2007-2010 in and around Delhi, India. PLoS One 2012, 7(1):e29129.
22. Tamura S., Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn J Infect Dis 2004, 57(6):236-247.
23. Puck J.M., Glezen W.P., Frank A.L., Six H.R. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 1980, 142(6):844-849.
24. Zinkernagel Maternal antibodies R.M. childhood infections, and autoimmune diseases. The N Engl J Med 2001, 345(18):1331-1335.
25. Mak T.K., Mangtani P., Leese J., Watson J.M., Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 2008, 8(1):44-52.
26. Dudareva S., Schweiger B., Thamm M., Höhle M., Stark K., Krause G., et al. Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre-and post-pandemic period. PLoS One 2011, 6(6):e21340.
27. Maltezou H.C., Katerelos P., Mavrouli M., Lourida A., Routsias J.G., Spanakis N., et al. Seroepidemiological study of pandemeic influenza H1N1 following the 2009-2010 wave in Greece. Vaccine 2011, 29:6664-6669.
28. Ikonen N., Strengell M., Kinnunen L., Österlund P., Pirhonen J., Broman M., et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Eurosurveillance 2010, 15(5):19478.